CLINICAL_TRIALS
trial_result
· 2010-09-29
Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients [Phase 3]
Summary
Phase 3 trial evaluating stem cell mobilization with AMD3100 (plerixafor) in multiple myeloma has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2010-09-29